Cor Vasa 2017, 59(2):e157-e162 | DOI: 10.1016/j.crvasa.2016.09.002

Imaging methods in cardiomyopathies

Pavel Gregor*, Hana Línková
III. interní-kardiologická klinika, Kardiocentrum 3. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice Královské Vinohrady, Praha, Česká republika

The echocardiography, as a widely available and relatively inexpensive basic imaging method, fulfills an irreplaceable function of a screening method in cardiomyopathies. Among new imaging methods, three-dimensional (3D) echocardiography may prove useful, particularly in spongious and apical hypertrophic cardiomyopathies; speckle-tracking echocardiography in differentiation of athletic heart from hypertrophic cardiomyopathy, various types of restrictive cardiomyopathy (including the initial stages of cardiac amyloidosis) and distinguishing between stress and spongious cardiomyopathy. More detailed information may be provided by cardiac magnetic resonance imaging, especially in arrhythmogenic right ventricular cardiomyopathy and the prognostic assessment in all types of cardiomyopathies. A cardiac CT scan serves particularly for discrimination of ischemic heart disease and detection of various extracardiac structures. Nevertheless, an essential disadvantage of this method is the radiation exposure, preventing its use in long-term follow-up.

Keywords: Arrhythmogenic right ventricular cardiomyopathy; Cardiac CT; Cardiomyopathy; Cardiovascular magnetic resonance; Echocardiography; Late gadolinium enhancement; Tissue Doppler imaging methods

Received: April 27, 2016; Revised: September 5, 2016; Accepted: September 7, 2016; Published: April 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gregor P, Línková H. Imaging methods in cardiomyopathies. Cor Vasa. 2017;59(2):e157-162. doi: 10.1016/j.crvasa.2016.09.002.
Download citation

References

  1. V. Jonáš, Klinická kardiologie, Praha: Zdravotnické nakladatelství Společnosti čs. lékařů, 1950, s. 735.
  2. F.G. Hage, P. Dean, S. Raslan, N.C. Nanda, Real time three-dimensional echocardiography for the evaluation of cardiomyopathy, Echocardiography 29 (2012) 76-87. Go to original source... Go to PubMed...
  3. S. Rajdev, A. Singh, N.C. Nanda, et al., Comparison of two- and three-dimensional transthoracic echocardiography in the assessment of trabeculations and trabecular mass in left ventricular noncompaction, Echocardiography 24 (2007) 760-767. Go to original source... Go to PubMed...
  4. P. Lupínek, T. Marek, Trojrozměrná echokardiografie v současné praxi, Cor et Vasa 53 (2011) 34-38.
  5. E.E. Frans, C.N. Nanda, V. Patel, et al., Live three-dimensional transthoracic contrast echocardiographic assessment of apical hypertrophic cardiomyopathy, Echocardiography 22 (2005) 686-689. Go to original source... Go to PubMed...
  6. J.M. Song, S. Fukuda, H.M. Lever, et al., Asymmetry of systolic anterior motion of the mitral valve in patients with hypertrophic obstructive cardiomyopathy: a real-time three-dimensional echocardiographic study, Journal of the American Society of Echocardiography 19 (2006) 1129-1136. Go to original source... Go to PubMed...
  7. C. de Gregorio, A. Recupero, P. Grimaldi, et al., Can transthoracic live 3-dimensional echocardiography improve the recognition of midventricular obliteration in hypertrophic obstructive cardiomyopathy?, Journal of the American Society of Echocardiography 19 (2006) e1-e4. Go to original source... Go to PubMed...
  8. C.A. Miller, K. Pearce, P. Jordan, et al., Comparison of real-time three-dimensional echocardiography with cardiovascular magnetic resonance for left ventricular volumetric assessment in unselected patients, European Heart Journal - Cardiovascular Imaging 13 (2012) 187-195. Go to original source... Go to PubMed...
  9. E. Mandysová, T. Mráz, P. Novák, Kam kráčíš echokardiografie?, Postgraduální Medicína 9 (2009) 977-980.
  10. M. Biswas, S. Sudhakar, N.C. Nanda, et al., Two- and three-dimensional speckle tracking echocardiography: clinical applications and future directions, Echocardiography 30 (2013) 88-105. Go to original source... Go to PubMed...
  11. M. Vachalcová, G. Valočik, M. Kurečko, Speckle tracking echocardiography and diagnosis of subclinical myocardial dysfunction past, present, future, Cardiology Letters 24 (2015) 19-24.
  12. J.-U. Voigt, G. Pedrizzetti, P. Lysyansky, et al., Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation paging, European Heart Journal - Cardiovascular Imaging 16 (2015) 1-11. Go to original source... Go to PubMed...
  13. T. Edvardsen, S. Plein, A. Saraste, et al., The year 2013 in the European Heart Journal - Cardiovascular Imaging Part I, European Heart Journal - Cardiovascular Imaging 15 (2014) 730-735. Go to original source... Go to PubMed...
  14. S. Plein, T. Edvardsen, L.A. Pierard, et al., The year 2013 in the European Heart Journal - Cardiovascular Imaging Part II, European Heart Journal - Cardiovascular Imaging 15 (2014) 837-841. Go to original source... Go to PubMed...
  15. S. Chen, J.S. Yuan, S.B. Qiao, et al., Evaluation of left ventricular function by global strain rate imaging in patients with obstructive hypertrophic cardiomyopathy: a simultaneous speckle tracking echocardiography and cardiac catheterization study, Echocardiography 31 (2014) 615-622. Go to original source... Go to PubMed...
  16. J.A. Urbano-Moral, E.J. Rowin, M.S. Maron, et al., Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy, Circulation - Cardiovascular Imaging 7 (2014) 11-19. Go to original source... Go to PubMed...
  17. J.F. Deux, T. Damy, A. Rahmouni, et al., Noninvasive detection of cardiac involvement in patients with hereditary transthyretin associated amyloidosis using cardiac magnetic resonance imaging: a prospective study, Amyloid - Journal of Protein Folding Disorders 21 (2014) 246-255. Go to original source... Go to PubMed...
  18. L.S. Tummala, R.K. Young, T. Singh, et al., Role of non-invasive imaging in the work-up of cardiomyopathies, Current Atherosclerosis Reports 17 (2015) 7-12. Go to original source... Go to PubMed...
  19. G. Limongelli, A. Rea, D. Masarone, et al., Tight ventricular cardiomyopathies: a multidisciplinary approach to diagnosis, Echocardiography 32 (Suppl 1) (2015) S75-S94. Go to original source... Go to PubMed...
  20. F.I. Marcus, W.J. McKenna, D. Sherrill, et al., Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria, Circulation 121 (2010) 1533-1541. Go to original source... Go to PubMed...
  21. B.J. Maron, S.R. Ommen, C. Semsarian, et al., Hypertrophic cardiomyopathy. Present and future, with translation into contemporary cardiovascular medicine, Journal of the American College of Cardiology 64 (2014) 83-99. Go to original source... Go to PubMed...
  22. K.Y. Kebed, R.I. Al Adham, K. Bishu, et al., Evaluation of apical pouches in hypertrophic cardiomyopathy using cardiac MRI, International Journal of Cardiovascular Imaging 30 (2014) 591-597. Go to original source... Go to PubMed...
  23. K. Gunaratnam, L.H. Wong, A. Nasis, et al., Review of cardiomyopathy imaging, European Journal of Radiology 82 (2013) 1763-1775. Go to original source... Go to PubMed...
  24. R. Blankstein, E.J. Rowin, What is the best paging test for patients with hypertrophic cardiomyopathy? It depends on the clinical question, Journal of Cardiovascular Computed Tomography 8 (2014) 438-441. Go to original source... Go to PubMed...
  25. J. Baxa, J. Ferda, R. Rokyta, et al., The role of cardiovascular contrast magnetic resonance in assessment of acute myocarditis, Česká Radiologie 63 (2009) 13-19.
  26. M. Kubánek, L. Voska, Giant cell myocarditis and cardiac sarcoidosis - update 2015, Kardiologická Revue - Interní Medicína 17 (2015) 295-299.
  27. C. Grigoratos, K. Bratis, M. Henningsson, et al., Chemotherapy-related cardiomyopathy in acute myeloid leukaemia assessed by cardiovascular magnetic resonance imaging, European Heart Journal - Cardiovascular Imaging 14 (2015) 1410. Go to original source...
  28. M. Grothoff, M. Pachowsky, J. Hoffmann, et al., Value of cardiovascular MR in diagnosing left ventricular non-compaction cardiomyopathy and in discriminating between other cardiomyopathies, European Radiology 22 (2012) 2699-2709. Go to original source... Go to PubMed...
  29. E. Bossone, A. Lyon, R. Citro, et al., Takotsubo cardiomyopathy: an integrated multi-imaging approach, European Heart Journal - Cardiovascular Imaging 15 (2014) 366-377. Go to original source... Go to PubMed...
  30. V.O. Putmann, R. Gebker, S. Duckett, et al., Left ventricular chamber dimensions and wall thickness by cardiovascular magnetic resonance: comparison with transthoracic echocardiography, European Heart Journal - Cardiovascular Imaging 14 (2013) 240-246. Go to original source... Go to PubMed...
  31. L.L. Mertens, M.K. Friedberg, Imaging the right ventricle - current state of the art, Nature Reviews. Cardiology 7 (2010) 551-563. Go to original source... Go to PubMed...
  32. R.H. Chan, B.J. Maron, I. Olivoto, et al., Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy, Circulation 130 (2014) 484-495. Go to original source... Go to PubMed...
  33. T. Yamada, A. Hirashiki, T. Okumura, et al., Prognostic impact of combined late gadolinium enhancement on cardiovascular magnetic resonance and peak oxygen consumption in ambulatory patients with nonischemic dilated cardiomyopathy, Journal of Cardiac Failure 20 (2014) 825-832. Go to original source... Go to PubMed...
  34. N. Ghosh, R.Y. Kwong, It's time to study cardiac magnetic resonance imaging as strategic tool in nonischemic cardiomyopathy, Circulation: Heart Failure 7 (2014) 391-393. Go to original source... Go to PubMed...
  35. P.G. Masci, C. Doulaptsis, E. Bertella, et al., Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure, Circulation: Heart Failure 7 (2014) 448-449. Go to original source... Go to PubMed...
  36. C. Doesch, D.M. Dierks, D. Haghi, et al., Right ventricular dysfunction, late gadolinium enhancement, and female gender predict poor outcome in patients with dilated cardiomyopathy, International Journal of Cardiology 177 (2014) 429-435. Go to original source... Go to PubMed...
  37. T. Nabeta, T. Inomata, Y. Iida, et al., Baseline cardiac magnetic resonance paging versus baseline endomyocardial biopsy for the prediction of left ventricular reverse remodeling and prognosis in response to therapy in patients with idiopathic dilated cardiomyopathy, Heart and Vessels 29 (2014) 784-792. Go to original source... Go to PubMed...
  38. G. Barone-Rochette, C. Augier, M. Rodiere, et al., Potentially simple score of late gadolinium enhancement cardiac MR in acute myocarditis, Journal of Magnetic Resonance Imaging 40 (2014) 1347-1354. Go to original source... Go to PubMed...
  39. G.Y. Liu, X. Yang, Y. Su, et al., Cardiovascular magnetic resonance imaging findings in children with myocarditis, Chinese Medical Journal 127 (2014) 3700-3705. Go to original source...
  40. G. Ashrith, D. Gupta, J. Hanmer, R.M. Weiss, Cardiovascular magnetic resonance characterization of left ventricular non-compaction provides independent prognostic information in patients with incident heart failure or suspected cardiomyopathy, Journal of Magnetic Resonance 16 (2014) 1347-1354. Go to original source... Go to PubMed...
  41. Y. Hen, N. Iguchi, Y. Utanohara, et al., Prognostic value of late gadolinium enhancement on cardiac magnetic resonance paging in Japanese hypertrophic cardiomyopathy patients, Circulation Journal 78 (2014) 929-937. Go to original source... Go to PubMed...
  42. G. Todiere, D. Aquaro, P. Piaggi, et al., Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy, Journal of the American College of Cardiology 60 (2012) 922-929. Go to original source... Go to PubMed...
  43. E.T. Hoey, J.K. Teoh, I. Das, et al., The emerging role of cardiovascular MRI for risk stratification in hypertrophic cardiomyopathy, Clinical Radiology 69 (2014) 221-230. Go to original source... Go to PubMed...
  44. K. Hanneman, A.M. Crean, L. Williams, et al., Cardiac magnetic resonance imaging findings predict major adverse events in apical hypertrophic cardiomyopathy, Journal of Thoracic Imaging 29 (2014) 331-339. Go to original source... Go to PubMed...
  45. B.M. Smith, A.L. Dorfman, S.K. Yu, et al., Clinical significance of late gadolinium enhancement in patients




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.